Ibaraki, Japan

Osamu Noshiro


Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Osamu Noshiro: Innovator in Pharmaceutical Chemistry

Introduction

Osamu Noshiro is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that enhance insulin sensitivity. With a total of 2 patents to his name, Noshiro's work is recognized for its potential impact on medical treatments.

Latest Patents

One of his latest patents is focused on a bisoxadiazolidine derivative, specifically a bisheterocyclic derivative or salt thereof. This invention includes a bisheterocyclic compound represented by a general formula, which encompasses various stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates. The compounds developed by Noshiro are particularly useful as hypoglycemic drugs, enhancing insulin sensitivity, which is crucial for managing diabetes.

Career Highlights

Osamu Noshiro is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development, particularly in the area of diabetes treatment.

Collaborations

Noshiro collaborates with esteemed colleagues such as Kunihiro Niigata and Takumi Takahashi. Their combined expertise fosters a productive environment for research and development in pharmaceutical innovations.

Conclusion

Osamu Noshiro's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve health outcomes for individuals with diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…